WO2009135939A3 - Pm02734 for use in the treatment of ewing' s sarcoma, osteosarcoma, rhabdomyosarcoma and medulloblastoma - Google Patents
Pm02734 for use in the treatment of ewing' s sarcoma, osteosarcoma, rhabdomyosarcoma and medulloblastoma Download PDFInfo
- Publication number
- WO2009135939A3 WO2009135939A3 PCT/EP2009/055604 EP2009055604W WO2009135939A3 WO 2009135939 A3 WO2009135939 A3 WO 2009135939A3 EP 2009055604 W EP2009055604 W EP 2009055604W WO 2009135939 A3 WO2009135939 A3 WO 2009135939A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- medulloblastoma
- rhabdomyosarcoma
- osteosarcoma
- sarcoma
- ewing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/15—Depsipeptides; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Abstract
Methods for treating cancer by using compound PM02734, in particular, for treating Ewing's sarcoma, osteosarcoma and rhabdomyosarcoma and medulloblastoma are provided.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08380145.6 | 2008-05-09 | ||
EP08380145 | 2008-05-09 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2009135939A2 WO2009135939A2 (en) | 2009-11-12 |
WO2009135939A3 true WO2009135939A3 (en) | 2010-04-29 |
Family
ID=41265075
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2009/055604 WO2009135939A2 (en) | 2008-05-09 | 2009-05-08 | Depsipeptide for use in cancer therapy |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2009135939A2 (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002036145A2 (en) * | 2000-10-31 | 2002-05-10 | Pharma Mar, S.A. | Kahalalide f formulation |
WO2004035613A2 (en) * | 2002-10-18 | 2004-04-29 | Pharma Mar, S.A.U. | 4-methylhexanoic kahalaide f compound |
-
2009
- 2009-05-08 WO PCT/EP2009/055604 patent/WO2009135939A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002036145A2 (en) * | 2000-10-31 | 2002-05-10 | Pharma Mar, S.A. | Kahalalide f formulation |
WO2004035613A2 (en) * | 2002-10-18 | 2004-04-29 | Pharma Mar, S.A.U. | 4-methylhexanoic kahalaide f compound |
Non-Patent Citations (1)
Title |
---|
ON BEHALF OF THE ITCC BIOLOGY AND PRECLINICAL EVALUATION COMMITTEE ET AL: "181 POSTER Evaluation of the marine compound PM02734 against a pediatric tumor cell line panel by ITCC preclinical drug evaluation program", EUROPEAN JOURNAL OF CANCER. SUPPLEMENT, PERGAMON, OXFORD, GB, vol. 6, no. 12, 1 October 2008 (2008-10-01), pages 57 - 58, XP025534243, ISSN: 1359-6349, [retrieved on 20081001] * |
Also Published As
Publication number | Publication date |
---|---|
WO2009135939A2 (en) | 2009-11-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL2358697T3 (en) | Isoindoline compounds for use in the treatment of cancer. | |
WO2007064872A3 (en) | Urea compounds useful in the treatment of cancer | |
HUE059861T2 (en) | N-substituted 2,5-dioxo-azoline compounds for use in the treatment of cancer | |
WO2008137867A3 (en) | Compositions comprising mir34 therapeutic agents for treating cancer | |
WO2007081879A3 (en) | Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis | |
WO2009129246A3 (en) | Compositions and methods for preparing and using same | |
WO2008054585A3 (en) | Use of pegylated il-10 to treat cancer | |
WO2009020802A3 (en) | Use of an fgf-21 compound and a glp-1 compound for the treatment of obesity | |
GB2442915B (en) | Perylenequinone derivatives and uses thereof | |
EP2134736A4 (en) | Five- and six-membered conformationally locked 2',4'- carbocyclic ribo-thymidines for the treatment of infections and cancer | |
HK1170485A1 (en) | 1,2,4-thiazolidin-3-one derivatives and their use in the treatment of cancer 124--3- | |
WO2010088450A3 (en) | Arylamide derivatives useful in the treatment of diseases associated with serca activity | |
BRPI0908635A8 (en) | compound, pharmaceutical composition and cancer treatment method | |
WO2010032011A3 (en) | Anti-fungal therapy | |
WO2010121164A3 (en) | 1,4-benzodiazepinone compounds and their use in treating cancer | |
WO2007047608A3 (en) | Fibrin targeted therapeutics | |
MX2008015775A (en) | Compounds and compositions for treatment of cancer. | |
WO2010074936A3 (en) | Enzastaurin for the treatment of cancer | |
EP2207555A4 (en) | Novel compounds for the treatment or alleviation of edema, and methods for their use | |
EP1865954A4 (en) | Methods for avoiding edema in the treatment or prevention of ppar gamma-responsive diseases, including cancer | |
ZA201000173B (en) | Method for treating an at least partially metallised textile, treated textile and the use thereof | |
AU2006251169A8 (en) | Tetrahydropyridothiophenes for use in the treatment of cancer | |
MX2009009693A (en) | Methods of activating irs-1 and akt. | |
WO2010149357A3 (en) | Methods of using corticotropin-releasing factor for the treatment of cancer | |
WO2009105507A3 (en) | Beloxepin, its enantiomers, and analogs thereof for the treatment of pain |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09742157 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 09742157 Country of ref document: EP Kind code of ref document: A2 |